Emma Tallantyre

25PUBLICATIONS
112CO-AUTHORS
Regenerative medicine (incl. stem cells)Epidemiological modellingMedical biotechnology diagnostics (incl. biosensors)Epigenetics (incl. genome methylation and epigenomics)Gene expression (incl. microarray and other genome-wide approaches)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (25)

|Aug 11, 2026
Natalizumab and Tyruko (natalizumab biosimilar) for treating highly active relapsing-remitting multiple sclerosis after at least one disease-modifying therapy: a systematic review and economic model.

|May 31, 2026
Disease-modifying treatment preferences and decision-making in a multiple sclerosis randomized and observational clinical trial (DELIVER-MS).

|Mar 30, 2026
A framework for blood biomarker discovery in MS.

Emma C Tallantyre, Sean Apap Mangion, Charlotte E Teunissen

|Mar 06, 2026
Genetic Determinants of Multiple Sclerosis Susceptibility in People From Diverse Ancestral Backgrounds.

Benjamin Meir Jacobs, Luisa Schalk, Emily Tregaskis-Daniels

|Jan 16, 2026
Genetic subtypes associated with multiple sclerosis severity and response to treatment.

Karim L Kreft, Nienke J Mekkes, Emeka Uzochukwu

|May 22, 2025
Real-world observational study of infections in people treated with ocrelizumab for multiple sclerosis.

Laura Davies, Rasheed Shehadeh, W John Watkins

Pageof 5

Frequent Collaborators

7 joint publications

Katharine Elizabeth Harding

6 joint publications

Ruth Dobson

6 joint publications

Nikos Evangelou

4 joint publications

Klaus Schmierer